CONGENITAL GENERALISED LIPODYSTROPHY

CONGENITAL GENERALISED LIPODYSTROPHY was reported 9 times

CONGENITAL GENERALISED LIPODYSTROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NELFINAVIR MESYLATE 1 0.0005
1 ETRAVIRINE 2 0.0005
2 NITROUS OXIDE 1 0.0005
3 ZIDOVUDINE 4 0.0004
4 LAMIVUDINE AND ZIDOVUDINE 2 0.0003
5 ACARBOSE 1 0.0003
6 ABACAVIR SULFATE 2 0.0002
7 RALTEGRAVIR 1 0.0002
8 DARUNAVIR 2 0.0001
9 PHYTONADIONE 1 0.0001
10 ICOSAPENT ETHYL 1 0.0001
11 INSULIN GLARGINE-YFGN 1 0.0000
12 EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 2 0.0000
13 VITAMIN E 1 0.0000
14 FENOFIBRATE 1 0.0000
15 INSULIN HUMAN 1 0.0000
16 PIOGLITAZONE 1 0.0000
17 0XYGEN 1 0.0000
18 OXYGEN 1 0.0000
19 METFORMIN HYDROCHLORIDE 1 0.0000
20 INSULIN ASPART 1 0.0000
21 IRON 1 0.0000
22 EZETIMIBE 1 0.0000
23 VITAMIN C 1 0.0000
24 PREDNISOLONE ORAL SOLUTION 1 0.0000
25 INSULIN GLARGINE 1 0.0000
26 LEVOTHYROXINE SODIUM 1 0.0000